Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

The poor performance of apps assessing skin cancer risk.

Morley J, Floridi L, Goldacre B.

BMJ. 2020 Feb 10;368:m428. doi: 10.1136/bmj.m428. No abstract available.

PMID:
32048610
2.

Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study.

DeVito NJ, Bacon S, Goldacre B.

Lancet. 2020 Feb 1;395(10221):361-369. doi: 10.1016/S0140-6736(19)33220-9. Epub 2020 Jan 17.

PMID:
31958402
3.

Barriers to Working With National Health Service England's Open Data.

Bacon S, Goldacre B.

J Med Internet Res. 2020 Jan 13;22(1):e15603. doi: 10.2196/15603.

4.

Why researchers should share their analytic code.

Goldacre B, Morton CE, DeVito NJ.

BMJ. 2019 Nov 21;367:l6365. doi: 10.1136/bmj.l6365. No abstract available.

PMID:
31753846
5.

Personalised Medicine Using N-of-1 Trials: Overcoming Barriers to Delivery.

Chalmers I, Smeeth L, Goldacre B.

Healthcare (Basel). 2019 Nov 5;7(4). pii: E134. doi: 10.3390/healthcare7040134.

6.
7.

Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? A cross-sectional analysis of English primary care prescribing data.

Goldacre B, Reynolds C, Powell-Smith A, Walker AJ, Yates TA, Croker R, Smeeth L.

BMJ Open. 2019 Feb 5;9(2):e026886. doi: 10.1136/bmjopen-2018-026886.

8.

COMPare: a prospective cohort study correcting and monitoring 58 misreported trials in real time.

Goldacre B, Drysdale H, Dale A, Milosevic I, Slade E, Hartley P, Marston C, Powell-Smith A, Heneghan C, Mahtani KR.

Trials. 2019 Feb 14;20(1):118. doi: 10.1186/s13063-019-3173-2.

9.

COMPare: Qualitative analysis of researchers' responses to critical correspondence on a cohort of 58 misreported trials.

Goldacre B, Drysdale H, Marston C, Mahtani KR, Dale A, Milosevic I, Slade E, Hartley P, Heneghan C.

Trials. 2019 Feb 14;20(1):124. doi: 10.1186/s13063-019-3172-3.

10.

Impact of Chief Medical Officer activity on prescribing of antibiotics in England: an interrupted time series analysis.

Walker AJ, Curtis HJ, Goldacre B.

J Antimicrob Chemother. 2019 Apr 1;74(4):1133-1136. doi: 10.1093/jac/dky528.

PMID:
30689889
11.

Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials.

Onakpoya IJ, Thomas ET, Lee JJ, Goldacre B, Heneghan CJ.

BMJ Open. 2019 Jan 21;9(1):e023600. doi: 10.1136/bmjopen-2018-023600. Review.

12.

Measuring the Impact of an Open Web-Based Prescribing Data Analysis Service on Clinical Practice: Cohort Study on NHS England Data.

Walker AJ, Curtis HJ, Croker R, Bacon S, Goldacre B.

J Med Internet Res. 2019 Jan 16;21(1):e10929. doi: 10.2196/10929.

13.

Why did some practices not implement new antibiotic prescribing guidelines on urinary tract infection? A cohort study and survey in NHS England primary care.

Croker R, Walker AJ, Goldacre B.

J Antimicrob Chemother. 2019 Apr 1;74(4):1125-1132. doi: 10.1093/jac/dky509.

PMID:
30590552
14.

Opioid prescribing trends and geographical variation in England, 1998-2018: a retrospective database study.

Curtis HJ, Croker R, Walker AJ, Richards GC, Quinlan J, Goldacre B.

Lancet Psychiatry. 2019 Feb;6(2):140-150. doi: 10.1016/S2215-0366(18)30471-1. Epub 2018 Dec 20.

PMID:
30580987
15.

Practice variation in the use of tests in UK primary care: a retrospective analysis of 16 million tests performed over 3.3 million patient years in 2015/16.

O'Sullivan JW, Stevens S, Oke J, Hobbs FDR, Salisbury C, Little P, Goldacre B, Bankhead C, Aronson JK, Heneghan C, Perera R.

BMC Med. 2018 Dec 20;16(1):229. doi: 10.1186/s12916-018-1217-1.

16.

Catalogue of bias: publication bias.

DeVito NJ, Goldacre B.

BMJ Evid Based Med. 2019 Apr;24(2):53-54. doi: 10.1136/bmjebm-2018-111107. Epub 2018 Dec 6. Review. No abstract available.

PMID:
30523135
17.

Six months on: NHS England needs to focus on dissemination, implementation and audit of its low-priority initiative.

Walker AJ, Bacon S, Curtis H, Croker R, MacKenna B, Goldacre B.

J R Soc Med. 2019 Jan;112(1):4-5. doi: 10.1177/0141076818808429. Epub 2018 Dec 3. No abstract available.

PMID:
30507285
18.

Temporal trends in use of tests in UK primary care, 2000-15: retrospective analysis of 250 million tests.

O'Sullivan JW, Stevens S, Hobbs FDR, Salisbury C, Little P, Goldacre B, Bankhead C, Aronson JK, Perera R, Heneghan C.

BMJ. 2018 Nov 28;363:k4666. doi: 10.1136/bmj.k4666. Erratum in: BMJ. 2019 Jan 29;364:l444.

19.

Transparency of the UK medicines regulator: auditing freedom of information requests and reasons for refusal.

Grigg SE, O'Sullivan JW, Goldacre B, Heneghan C.

BMJ Evid Based Med. 2019 Feb;24(1):20-25. doi: 10.1136/bmjebm-2018-111018. Epub 2018 Oct 30. No abstract available.

PMID:
30377149
20.

Too few trials or too few reported trials?

Viteri-García A, DeVito NJ, Goldacre B.

Evid Based Dent. 2018 Oct;19(3):67-68. doi: 10.1038/sj.ebd.6401317. No abstract available.

PMID:
30361651
21.

Time trends and geographical variation in prescribing of antibiotics in England 1998-2017.

Curtis HJ, Walker AJ, Mahtani KR, Goldacre B.

J Antimicrob Chemother. 2019 Jan 1;74(1):242-250. doi: 10.1093/jac/dky377.

PMID:
30239809
22.

Compliance with requirement to report results on the EU Clinical Trials Register: cohort study and web resource.

Goldacre B, DeVito NJ, Heneghan C, Irving F, Bacon S, Fleminger J, Curtis H.

BMJ. 2018 Sep 12;362:k3218. doi: 10.1136/bmj.k3218.

23.

Reply to Comment on 'Impact of NICE guidance on tamoxifen prescribing in England 2011-2017: an interrupted time series analysis".

Curtis H, Goldacre B.

Br J Cancer. 2018 Aug;119(5):658. doi: 10.1038/s41416-018-0226-3. Epub 2018 Aug 21. No abstract available.

24.

Why Cochrane should prioritise sharing data.

Shokraneh F, Adams CE, Clarke M, Amato L, Bastian H, Beller E, Brassey J, Buchbinder R, Davoli M, Del Mar C, Glasziou P, Gluud C, Heneghan C, Hoffmann T, Ioannidis JP, Jayaram M, Kwong J, Moher D, Ota E, Sheriff RS, Vale L, Goldacre B.

BMJ. 2018 Jul 30;362:k3229. doi: 10.1136/bmj.k3229. No abstract available. Erratum in: BMJ. 2018 Aug 15;362:k3542.

PMID:
30061322
25.

Prescribing biosimilars.

Aronson JK, Goldacre B, Ferner RE.

BMJ. 2018 Jul 24;362:k3141. doi: 10.1136/bmj.k3141. No abstract available.

PMID:
30042142
26.

Detecting change in comparison to peers in NHS prescribing data: a novel application of cumulative sum methodology.

Walker AJ, Bacon S, Croker R, Goldacre B.

BMC Med Inform Decis Mak. 2018 Jul 9;18(1):62. doi: 10.1186/s12911-018-0642-6.

27.

The clinician impact and financial cost to the NHS of litigation over pregabalin: a cohort study in English primary care.

Croker R, Smyth D, Walker AJ, Goldacre B.

BMJ Open. 2018 Jun 7;8(6):e022416. doi: 10.1136/bmjopen-2018-022416. Erratum in: BMJ Open. 2018 Jun 30;8(6):.

28.

Pregabalin: what the patent litigation means for doctors and drug companies.

Smyth D, Croker R, Goldacre B.

BMJ. 2018 Jun 7;361:k2318. doi: 10.1136/bmj.k2318. No abstract available.

PMID:
29880536
29.

Author Correction: Variation in diagnostic test requests and outcomes: a preliminary metric for OpenPathology.net.

O'Sullivan JW, Heneghan C, Perera R, Oke J, Aronson JK, Shine B, Goldacre B.

Sci Rep. 2018 May 24;8(1):8354. doi: 10.1038/s41598-018-26376-7.

30.

Trends and variation in prescribing of low-priority treatments identified by NHS England: a cross-sectional study and interactive data tool in English primary care.

Walker AJ, Curtis HJ, Bacon S, Croker R, Goldacre B.

J R Soc Med. 2018 Jun;111(6):203-213. doi: 10.1177/0141076818769408. Epub 2018 May 22.

31.

Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017.

Curtis HJ, Dennis JM, Shields BM, Walker AJ, Bacon S, Hattersley AT, Jones AG, Goldacre B.

Diabetes Obes Metab. 2018 Sep;20(9):2159-2168. doi: 10.1111/dom.13346. Epub 2018 Jun 5.

32.

Noncommercial Funders' Policies on Trial Registration, Access to Summary Results, and Individual Patient Data Availability.

DeVito NJ, French L, Goldacre B.

JAMA. 2018 Apr 24;319(16):1721-1723. doi: 10.1001/jama.2018.2841. No abstract available.

33.

Impact of NICE guidance on tamoxifen prescribing in England 2011-2017: an interrupted time series analysis.

Curtis HJ, Walker AJ, Goldacre B.

Br J Cancer. 2018 May;118(9):1268-1275. doi: 10.1038/s41416-018-0065-2. Epub 2018 Apr 23.

34.

Is use of homeopathy associated with poor prescribing in English primary care? A cross-sectional study.

Walker AJ, Croker R, Bacon S, Ernst E, Curtis HJ, Goldacre B.

J R Soc Med. 2018 May;111(5):167-174. doi: 10.1177/0141076818765779. Epub 2018 Apr 18.

35.

Trends, geographical variation and factors associated with prescribing of gluten-free foods in English primary care: a cross-sectional study.

Walker AJ, Curtis HJ, Bacon S, Croker R, Goldacre B.

BMJ Open. 2018 Apr 16;8(3):e021312. doi: 10.1136/bmjopen-2017-021312.

36.

A cross-sectional study of all clinicians' conflict of interest disclosures to NHS hospital employers in England 2015-2016.

Feldman HR, DeVito NJ, Mendel J, Carroll DE, Goldacre B.

BMJ Open. 2018 Mar 5;8(3):e019952. doi: 10.1136/bmjopen-2017-019952.

37.

Variation in diagnostic test requests and outcomes: a preliminary metric for OpenPathology.net.

O'Sullivan JW, Heneghan C, Perera R, Oke J, Aronson JK, Shine B, Goldacre B.

Sci Rep. 2018 Mar 19;8(1):4752. doi: 10.1038/s41598-018-23263-z. Erratum in: Sci Rep. 2018 May 24;8(1):8354.

38.
39.

OpenPrescribing: normalised data and software tool to research trends in English NHS primary care prescribing 1998-2016.

Curtis HJ, Goldacre B.

BMJ Open. 2018 Feb 23;8(2):e019921. doi: 10.1136/bmjopen-2017-019921.

40.

New mechanism to identify cost savings in English NHS prescribing: minimising 'price per unit', a cross-sectional study.

Croker R, Walker AJ, Bacon S, Curtis HJ, French L, Goldacre B.

BMJ Open. 2018 Feb 8;8(2):e019643. doi: 10.1136/bmjopen-2017-019643.

41.

Transvaginal mesh failure: lessons for regulation of implantable devices.

Heneghan C, Aronson JK, Goldacre B, Mahtani KR, Plüddemann A, Onakpoya I.

BMJ. 2017 Dec 7;359:j5515. doi: 10.1136/bmj.j5515. No abstract available.

PMID:
29217786
42.

Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process.

Heneghan CJ, Goldacre B, Onakpoya I, Aronson JK, Jefferson T, Pluddemann A, Mahtani KR.

BMJ Open. 2017 Dec 6;7(12):e017125. doi: 10.1136/bmjopen-2017-017125. Review.

43.

Study protocol for statin web-based investigation of side effects (StatinWISE): a series of randomised controlled N-of-1 trials comparing atorvastatin and placebo in UK primary care.

Herrett E, Williamson E, Beaumont D, Prowse D, Youssouf N, Brack K, Armitage J, Goldacre B, MacDonald T, Staa TV, Roberts I, Shakur-Still H, Smeeth L.

BMJ Open. 2017 Dec 1;7(12):e016604. doi: 10.1136/bmjopen-2017-016604.

44.

Pharmaceutical companies' policies on access to trial data, results, and methods: audit study.

Goldacre B, Lane S, Mahtani KR, Heneghan C, Onakpoya I, Bushfield I, Smeeth L.

BMJ. 2017 Jul 26;358:j3334. doi: 10.1136/bmj.j3334.

45.

Evidence based medicine manifesto for better healthcare: A response to systematic bias, wastage, error and fraud in research underpinning patient care.

Heneghan C, Mahtani KR, Goldacre B, Godlee F, Macdonald H, Jarvies D.

Evid Based Med. 2017 Aug;22(4):120-122. doi: 10.1136/ebmed-2017-j2973rep. Epub 2017 Jul 18. No abstract available.

PMID:
28720642
46.

Assessment of Conflicts of Interest in Robotic Surgical Studies: Validating Author's Declarations With the Open Payments Database.

Patel SV, Yu D, Elsolh B, Goldacre BM, Nash GM.

Ann Surg. 2018 Jul;268(1):86-92. doi: 10.1097/SLA.0000000000002420.

47.

Focus on sharing individual patient data distracts from other ways of improving trial transparency.

Hoffmann T, Glasziou P, Beller E, Goldacre B, Chalmers I.

BMJ. 2017 Jun 22;357:j2782. doi: 10.1136/bmj.j2782. Review. No abstract available.

PMID:
28642275
48.

Evidence based medicine manifesto for better healthcare.

Heneghan C, Mahtani KR, Goldacre B, Godlee F, Macdonald H, Jarvies D.

BMJ. 2017 Jun 20;357:j2973. doi: 10.1136/bmj.j2973. No abstract available.

PMID:
28634227
49.

The WHO joint statement from funders on trials transparency.

Goldacre B.

BMJ. 2017 Jun 19;357:j2816. doi: 10.1136/bmj.j2816. No abstract available.

PMID:
28630142
50.

Why clinical trial outcomes fail to translate into benefits for patients.

Heneghan C, Goldacre B, Mahtani KR.

Trials. 2017 Mar 14;18(1):122. doi: 10.1186/s13063-017-1870-2.

Supplemental Content

Loading ...
Support Center